Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Anesthetics could have long-term impact on children's brains

  • Beliefs can regulate effects of nicotine on the human brain

  • How central are online social networks to our lives?

  • Robust evidence that chronic fatigue syndrome is a biological illness

  • Image-guided treatment shown to break the migraine cycle

  • Virtual patient: Avatar shows emotions as he talks to med students

  • Psychology of food choice: Challenging the status quo

  • Can money buy happiness? The relationship between money and well-being

  • Finding psychological insights through social media

  • How does the human brain tackle problems it did not evolve to solve?

  •